1. Academic Validation
  2. Mus Musculus papillomavirus MmuPV1 resists restriction by human APOBEC3B

Mus Musculus papillomavirus MmuPV1 resists restriction by human APOBEC3B

  • bioRxiv. 2025 Nov 10:2025.11.10.687577. doi: 10.1101/2025.11.10.687577.
Xingyu Liu 1 Andrea Bilger 2 Denis Lee 2 Prokopios P Argyris 3 Jiarui Chen 4 5 Ella Ward-Shaw 2 Emilia Barreto Duran 1 Yu-Hsiu T Lin 1 Cameron Durfee 1 Sang Hyun Chun 1 Mahmoud Ibrahim 1 Joshua Proehl 1 Allen J York 1 6 Paul F Lambert 2 Reuben S Harris 1 6
Affiliations

Affiliations

  • 1 Department of Biochemistry and Structural Biology, University of Texas at San Antonio, San Antonio, Texas, USA.
  • 2 McArdle Laboratory for Cancer Research, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • 3 Department of Pathology, University of Chicago Medicine, Chicago, Illinois, USA.
  • 4 Division of Surgical Oncology, Department of Surgery, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • 5 Center for Precision Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • 6 Howard Hughes Medical Institute, University of Texas at San Antonio, San Antonio, Texas, USA.
Abstract

The single-stranded DNA deaminase APOBEC3B (A3B) is capable of potently restricting the replication of a range of viruses including retroviruses (cDNA) and herpesviruses (genomic DNA). However, these and likely Other DNA virus families have evolved host species-specific counter-defenses that are equally potent and serve to protect viral DNA from restriction. Although high-risk human papillomavirus (HPV) Infection triggers A3B upregulation, potentially as part of an Antiviral response, the impact of this restriction factor on papillomavirus replication and pathogenesis has yet to be assessed. To study human A3B Antiviral function in the absence of a species-specific counter-defense, here we ask whether human A3B is capable of restricting Mus musculus papillomavirus (MmuPV1) in cellulo and in vivo. First, we created human A3B and catalytic mutant A3B-E255A expressing FVB/N mice. Second, MmuPV1 gene expression and replication was quantified in primary keratinocytes from these Animals and, surprisingly, enzymatically active human A3B caused no measurable impairment in viral transcript or DNA accumulation. Third, A3B, catalytic mutant A3B-E255A, and nontransgenic FVB/N Animals were infected with MmuPV1 and similar pathologies were found regardless of A3B functionality. Thus, despite likely never being exposed to human A3B during evolution, MmuPV1 appears to be unaffected by this potent, primate-specific Antiviral factor. These results suggest that MmuPV1 and perhaps papillomaviruses more broadly possess a conserved mechanism to efficiently escape restriction by human A3B and related DNA deaminases.

Keywords

APOBEC3B (A3B); innate antiviral immunity; papillomavirus; small DNA tumor virus; virus restriction mechanisms; virus-host interactions.

Figures
Products